Good question. Sadly, I've not gone that deep yet. There was a lot of procrastination to get to yesterday's summary, but hope there will be less in the next phase. It's my intent to look at the trajectory for each drug, approval by phase and all that, to see if there are any conclusions that can be drawn. Strange hobby, I know, but what can I say...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.